These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 25361191

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nephrotoxicity of amphotericin B desoxycholate.
    Girmenia C, Gentile G, Micozzi A, Martino P.
    Clin Infect Dis; 2001 Sep 15; 33(6):915-6. PubMed ID: 11512101
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Amphotericin B deoxycholate prescription and adverse events in a Chilean university hospital].
    Quinteros A R, Fica C A, Abusada A N, Muñoz C L, Novoa M C, Gallardo A C.
    Rev Chilena Infectol; 2010 Feb 15; 27(1):25-33. PubMed ID: 20140311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial.
    Hasibi M, Jafari S, Manshadi SA, Asadollahi M, Salehi M, Zarch VV, Kouhi A.
    Ear Nose Throat J; 2017 Feb 15; 96(2):E18-E22. PubMed ID: 28231371
    [Abstract] [Full Text] [Related]

  • 11. continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis.
    Falagas ME, Karageorgopoulos DE, Tansarli GS.
    PLoS One; 2013 Feb 15; 8(10):e77075. PubMed ID: 24204739
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.
    Hamill RJ, Sobel JD, El-Sadr W, Johnson PC, Graybill JR, Javaly K, Barker DE.
    Clin Infect Dis; 2010 Jul 15; 51(2):225-32. PubMed ID: 20536366
    [Abstract] [Full Text] [Related]

  • 13. What is the current and future status of conventional amphotericin B?
    Kleinberg M.
    Int J Antimicrob Agents; 2006 Jun 15; 27 Suppl 1():12-6. PubMed ID: 16707251
    [Abstract] [Full Text] [Related]

  • 14. Reduction of nephrotoxicity associated with amphotericin B deoxycholate.
    Johnson JR.
    Clin Infect Dis; 2004 Jan 15; 38(2):303; author reply 306-7. PubMed ID: 14699469
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignancies.
    Schulenburg A, Sperr W, Rabitsch W, Knöbl P, Thalhammer F.
    Leuk Lymphoma; 2005 Aug 15; 46(8):1163-7. PubMed ID: 16085557
    [Abstract] [Full Text] [Related]

  • 19. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
    Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K, Itraconazole Neutropenia Study Group.
    Ann Intern Med; 2001 Sep 18; 135(6):412-22. PubMed ID: 11560454
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.